mouse cfd (R&D Systems)
Structured Review

Mouse Cfd, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 15 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/complement+factor+antibodies/Mouse+Complement+Factor+D%2FAdipsin+Antibody/pmc13128952-365-19-22
Average 93 stars, based on 15 article reviews
Images
1) Product Images from "Targeting adipocyte ESRRA alleviates osteoarthritis via interrupting inter-organelle crosstalk of complement C3-CFD-MAC cascade"
Article Title: Targeting adipocyte ESRRA alleviates osteoarthritis via interrupting inter-organelle crosstalk of complement C3-CFD-MAC cascade
Journal: Bone Research
doi: 10.1038/s41413-026-00527-3
Figure Legend Snippet: Adipocyte ESRRA positively regulates Cfd transcriptional expression responding to bone marrow adipocytes expansion. a Venn diagram of overlapping differentially expressed genes from RNA-seq of HFHC-fed gWAT and BMAds lineage cells in Esrra fl/fl and Esrra AKO mice ( GSE248799 ), identifying six downregulated genes encoding secreted factors. b Heatmap of selected genes. c Cf d mRNA in HFHC-fed gWAT ( n = 6) and fully differentiated mBMAds ( n = 5). d Schematic of ERRE binding sites on the mouse Cfd promoter, with ChIP fragments indicated as region 1 and 2 (R1, R2). e Luciferase activity of Cfd promoter in 3T3‑L1 cells transfected with Esrra or Ppargc1a expression plasmids ( n = 5). f Effects of compound 29 (C29) or andrographolide (AP) on ESRRA/PPARGC1A- driven Cfd promoter activity ( n = 5). g Luciferase activities of the R2-deleted (ΔR2-luc), S2-mutated (MutS2-luc) and wild-type (WT-luc) Cfd promoter ( n = 5). h ChIP assays with ESRRA antibody or IgG control in BMSCs after 4 days of adipogenic induction, with cells infected with ESRRA- or GFP-expressing adenovirus ( n = 4). i Enrichment of ESRRA at Cfd promoter in BMSCs undergoing adipogenic induction from Esrra fl/fl and Esrra AKO mice ( n = 4). j , k Immunoblots of serum CFD from HFHC-fed ( j ) and aged ( k ) groups versus control diet (CD). Ponceau S as loading control (L.C). l Serum CFD levels ( n = 6). m , n Immunoblots of CFD and Leptin in gWAT from Esrra fl/fl and Esrra AKO mice as in ( j , k ). o CFD concentrations from culture medium of gWAT explants as in ( j , k ) ( n = 5). p , q Immunoblots of bone marrow CFD as in ( j , k ). r Protein levels of ESRRA, CFD and Leptin in BMSCs and mBMAds with treatment of dexamethasone (DEX) with or without rosiglitazone (Rosi). Data are shown as mean ± SD. Statistical analysis is performed using two-sided unpaired Student’s t -test ( c ), two-way ANOVA with post-hoc Turkey’s multiple comparisons test ( l , o )
Techniques Used: Expressing, RNA Sequencing, Binding Assay, Luciferase, Activity Assay, Transfection, Control, Infection, Western Blot
Figure Legend Snippet: Reduced CFD from Esrra -ablated BMAds interrupts C3-CFD-MAC cascade-mediated mitochondrial dysfunction, senescence and catabolism in chondrocytes. a , b Representative images ( a ) and quantification ( b ) of MAC and pERK1/2 positive staining in cartilage regions of HFHC-fed or 25-month-old Esrra fl/fl and Esrra AKO mice. Scale bar, 100 μm. n = 6 mice. c Diagram depicting primary wild-type chondrocytes treated with the indicated conditioned medium (CM) collected from mBMAds, with or without supplementation of 1 μg/mL mouse recombinant C3 (mC3). d Soluble CFD concentrations from BMAds CM prepared as in ( c ) ( n = 6). e mRNA levels of degradative enzymes Mmp13 , Mmp3 , Mmp9 , Adamts4 , Adamts5 and senescent/proinflammatory markers P16 , P53 , P21 , IL6 in co-cultured primary chondrocytes as in ( c ) ( n = 5). f Protein levels of pERK1/2, ERK1/2, P21, MMP13 and COL2A1 in co-cultured primary chondrocytes as in ( c ). g , h Immunofluorescence staining of MAC, pERK1/2, MitoTracker Red, MitoSOX Red, γH2AX, P21 and Ki67, as well as SA-β-gal staining in co-cultured primary chondrocytes ( g ). Quantitative analysis results are shown in ( h ) ( n = 4). DAPI or Hoechst was used for nuclear counterstaining. Scale bar, 10 μm. i Oxygen Consumption Rate (OCR) were measured in co-cultured primary chondrocytes as in ( c ). Bar chart showing the results of mitochondrial basal and maximal respiratory capacity changes ( n = 9). Data are shown as mean ± SD. Statistical analysis is performed using two-sided unpaired Student’s t -test ( b , d ), two-way ANOVA with post-hoc Turkey’s multiple comparisons test ( e , h , i )
Techniques Used: Staining, Recombinant, Cell Culture, Immunofluorescence
Figure Legend Snippet: Inhibition of adipocyte ESRRA/CFD signaling rescues chondrocyte from damage caused by excessive hepatocytes-derived C3 under metabolic stress conditions. a Boxplots depicting C3 gene expression levels in MASLD/MASH patients compared to healthy controls from European ( GSE135251 ) and American ( GSE24807 ) cohorts. Data are represented as box and whiskers with bars representing maximum and minimum values and with median highlighted as a line. b Immunoblot analysis of C3 expression in livers from female mice at various time points following OVX (left) and male mice across different ages (right). c Representative liver images of the livers from HFHC-fed or 25-month-old Esrra fl/fl and Esrra AKO mice as well as corresponding controls. d Protein levels of C3 in the livers as in ( c ). e ELISA analysis of serum C3 concentrations. n = 6 mice per group. f The expression and secretion of C3 protein in primary hepatocytes following treatment with 40 μmol/L cholesterol (Chol) or a mixture of 250 μmol/L oleic acid (OA)/125 μmol/L palmitic acid (PA) for 24 hours (n = 4). g Diagram illustrating the co-culture system involving mBMAds CM, mouse primary hepatocytes and chondrocytes. h Western blot analysis of pERK1/2, ERK1/2, P21, MMP13 and COL2A1 in co-cultured primary chondrocytes as in ( g ). i , j Representative images ( i ) and quantitative analysis ( j ) of MAC, pERK1/2, MitoTracker Red, MitoSOX Red, γH2AX, P21, Ki67 and SA-β-gal staining in chondrocytes as in ( g ) ( n = 4). DAPI or Hoechst was used for counterstaining of nuclei. Scale bar, 10 μm. Data are shown as mean ± SD. Statistical analysis is performed using two-sided unpaired Student’s t -test (right panel of a ), two-way ANOVA with post-hoc Turkey’s multiple comparisons test ( e , j ), one-way ANOVA followed by Bonferroni’s post hoc tests (left panel of a , f )
Techniques Used: Inhibition, Derivative Assay, Gene Expression, Western Blot, Expressing, Enzyme-linked Immunosorbent Assay, Co-Culture Assay, Cell Culture, Staining
Figure Legend Snippet: Suppressing CFD by Danicopan or andrographolide confers protection against cellular senescence and catabolism in human C28/I2 chondrocytes. a Scatter plot showing plasma CFD levels across the lifespan were analyzed using a public proteome dataset (see Method for details). RFU, relative fluorescent unit. b Illustration of the co-culture system involving C28/I2 chondrocytes and conditioned medium (CM) obtained from AP-treated human BMAds (hBMAds), with an additional treatment of 1 μg/mL human recombinant C3 (hC3) and/or 10 mmol/L Danicopan. c Western blot analysis of ESRRA, CFD and Leptin protein levels in human BMSCs-derived BMAds treated with 40 μmol/L AP or DMSO for 2 days. d Western blot analysis of pERK1/2, ERK1/2, P21, MMP13, and COL2A1 protein levels in human C28/I2 chondrocytes as in ( b ). e , f Representative images ( e ) and corresponding quantitative data ( f ) of MAC, pERK1/2, MitoTracker Red, MitoSOX Red, γH2AX, P21, Ki67 and SA-β-gal staining in human C28/I2 chondrocytes as in ( b ) ( n = 4). DAPI or Hoechst was used for nuclear counterstaining. Scale bar, 10 μm. Data are shown as mean ± SD. Statistical analysis is performed using two-way ANOVA with post-hoc Turkey’s multiple comparisons test
Techniques Used: Clinical Proteomics, Co-Culture Assay, Recombinant, Western Blot, Derivative Assay, Staining
Figure Legend Snippet: Pharmacological inhibition of ESRRA by andrographolide protects aged mice against spontaneous osteoarthritis progression. a Schematic diagram of the experimental design for pharmacological treatments in mice. 22-month-old male C57BL/6 mice were administered intragastrically (i.g.) with either vehicle or AP (100 mg/kg body weight) five times per week for 3 months. Young controls were 3-month-old male mice. b Representative images of WAT depots and livers, along with WAT weight analysis. c Liver TC and TG levels. d Immunoblots of C3 in liver tissues. e Serum C3 levels. f Immunoblots of bone marrow CFD and Leptin. g Serum CFD levels. h , i Immunofluorescence of PLIN1 staining ( h ) and quantification of PLIN1 + bone marrow adipocytes area ( i ). Scale bar, 100 μm. j Representative SO&FG-stained joint sections and H&E-stained synovial tissue. Scale bar, 100 μm. k , l OARSI score ( k ) and synovitis score ( l ). m Digital microCT images of knee joints. n , Quantitative data of the volume of calcified meniscus and synovial tissue. o , p Immunofluorescence staining for MAC and pERK1/2 in articular cartilage ( o ) and the quantitation ( p ). Scale bar, 100 μm. q – t Immunofluorescence staining ( q , r ) and quantification ( s , t ) of p21, Ki67, MMP13 and COL2A1. Scale bar, 100 μm. u A proposed model illustrates that ESRRA-mediated adipocyte CFD and liver-derived C3 synergistically promote osteoarthritis progression in aging and metabolic disorders. ESRRA transcriptionally upregulates CFD responding to MAT expansion. Together with steatotic liver-derived C3, this triggers excessive alternative complement activation, resulting in MAC deposition on chondrocytes, therefore provoking pERK1/2 activation and mitochondrial dysfunction. Targeting ESRRA alleviates osteoarthritis by interrupting this inter-organ C3-CFD-MAC cascade. For all experiments, n = 6 mice. Data are shown as mean ± SD. Statistical analysis is performed using two-way ANOVA with post-hoc Turkey’s multiple comparisons test
Techniques Used: Inhibition, Western Blot, Immunofluorescence, Staining, Quantitation Assay, Derivative Assay, Activation Assay
Related Articles
Incubation:Article Title: Proteomic analysis reveals angiogenesis-related plasma proteins associated with pre-eclampsia in SLE. Article Snippet: .. 96- well half- area microplates (#3690, Corning) were coated with Article Title: A novel fusion protein reduces kidney complement in experimental C3 glomerulopathy Article Snippet: .. After incubation and washing, bound FHR5 1-9 FH 1-5 was detected using Article Title: Proteomic analysis reveals angiogenesis-related plasma proteins associated with pre-eclampsia in SLE. Article Snippet: After washing plates once with 0.05% tween in PBS, plasma samples and standard Recombinant Human FGF- 5 Protein (#3845- F5- 050, R&D Systems) were added and incubated for 2 hour at RT. .. After washing three times, Article Title: Sialoglycoconjugate Profiling of Human Choroid, Retinal Pigment Epithelium, and Macular Degeneration Related Lesions Article Snippet: After washes, sections were incubated with 25 μg/mL avidin-Texas red, 2.5 μg/mL donkey anti-rabbit IgG Alexa Fluor 647 (Invitrogen #A-31573, Waltham, MA), 2.5 μg/mL donkey anti-mouse IgG Alexa Fluor 488 (Invitrogen #A-21202, Waltham, MA), and 0.2 μg/mL DAPI for 45 minutes. .. For the second set, sections were first incubated with 25 μg/mL Article Title: Peroxisome Proliferator-Activated Receptor Gamma (PPARγ)-targeted Gel/Mg/Lip@Gigantol nanoplatform attenuates skin barrier disruption-associated aging in mice via NLRP3 suppression. Article Snippet: Skin aging serves as a critical indicator of systemic health decline.. Despite Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) being a key therapeutic target, mechanistic understanding remains incomplete and potent, safe activators are lacking, hindering clinical progress.. This study proposes the “Barrier-Skin-Systemic Aging Axis,” demonstrating that epidermal barrier disruption accelerates aging via PPARγ suppression. Article Title: Identification of an Intracellular Role for Complement Factor D: Lipid Droplet Biogenesis in Differentiating Adipocytes. Article Snippet: Complement factor D (CFD, also known as adipsin) is a secreted serine protease classically known for activating the alternative complement pathway and regulating systemic metabolism.. Although CFD is highly expressed in adipocytes, its roles in adipogenesis remain to be elucidated.. Here, we show that intracellularly localized CFD promoted lipid droplet (LD) formation in its catalytic activityindependent manner. Concentration Assay:Article Title: Factor H-related 1 and heparan sulfate architecture contribute to complement dysregulation in C3 glomerulopathy Article Snippet: .. In brief, 96-well flat bottom plates (Corning Incorporated, Corning, NY) were coated overnight with a |